Funding for this research was provided by:
National Institutes of Health (D43TW010540, D43 TW010037)
National Institutes of Health (D43TW010132)
Received: 2 January 2020
Accepted: 15 April 2020
First Online: 4 May 2020
Ethics approval and consent to participate
: This study was approved by the TASO Institutional Review Board (IRB) number TASOREC/65/17-UG-REC-009 and the Uganda National Council for Science and Technology (UNCST) number SS4583. Permission (written consent) to access the HIV clinics and medical records was sought from the DHO and health facility in-charges respectively. Written informed consent was sought from each participant after explaining the purpose of the study, benefits, approximate time of interview, and an assurance of confidentiality of the study results. Selected individuals were asked if they would like to participate, and if the response was affirmative, the interviewer would give them a consent form to be signed as evidence of acceptance to take part in the study. In case a participant was not willing to be audio recorded for key informant or in-depth interviews, interview notes were taken. Privacy was maintained during data collection, analysis, and storage. All identifiable information were removed from final records after data collection to ensure participant anonymity, and only the core research team and PIs had access to the de-identified data.
: Not applicable
: The authors declare that they have no competing interests.